Fig. 2From: Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinomaDown-regulated mRNA of BCL2L13 in ccRCC and pRCC is independent of patients’ race (A), gender (B), age (C), lymph node metastasis status (D), clinical stages (E) and tumor subtypes (F) (CIMP, CpG island methylator phenotype). TPM values and Student's t tests were employed to compute the significance of gene expression divergenceBack to article page